GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Klaria Pharma Holding AB (STU:6FN) » Definitions » 3-Year Revenue Growth Rate

Klaria Pharma Holding AB (STU:6FN) 3-Year Revenue Growth Rate : 0.00% (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Klaria Pharma Holding AB 3-Year Revenue Growth Rate?

Klaria Pharma Holding AB's Revenue per Share for the three months ended in Sep. 2024 was €0.00.

During the past 12 months, Klaria Pharma Holding AB's average Revenue per Share Growth Rate was -155.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 10 years, the highest 3-Year average Revenue per Share Growth Rate of Klaria Pharma Holding AB was -7.40% per year. The lowest was -7.40% per year. And the median was -7.40% per year.


Competitive Comparison of Klaria Pharma Holding AB's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Klaria Pharma Holding AB's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Klaria Pharma Holding AB's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Klaria Pharma Holding AB's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Klaria Pharma Holding AB's 3-Year Revenue Growth Rate falls into.



Klaria Pharma Holding AB 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Klaria Pharma Holding AB  (STU:6FN) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Klaria Pharma Holding AB 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Klaria Pharma Holding AB's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Klaria Pharma Holding AB Business Description

Traded in Other Exchanges
Address
Virdings Alle 2, Uppsala, SWE, 754 50
Klaria Pharma Holding AB is engaged in the development and commercialization of pharmaceutical products in Sweden for migraine and cancer-related pain. Its operations are based on a patented drug delivery platform in the form of an alginate-based polymer film. Majority of the group's operations are conducted in Sweden.

Klaria Pharma Holding AB Headlines

No Headlines